A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis

MLA

Joanna, Huszno, et al. “A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis.” Oncology, vol. 90, no. 4, Sept. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8584cc1b4f175ca8cdeb8e3408f237df&authtype=sso&custid=ns315887.

APA

Joanna, H., Magdalena, B., Zofia, K., Karolina, T., Jolanta, P. P., Elżbieta, N., & Ewa, G. (2015). A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis. Oncology, 90(4).

Chicago

Joanna, Huszno, Budryk Magdalena, Kołosza Zofia, Tęcza Karolina, Pamuła Piłat Jolanta, Nowara Elżbieta, and Grzybowska Ewa. 2015. “A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis.” Oncology 90 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8584cc1b4f175ca8cdeb8e3408f237df&authtype=sso&custid=ns315887.